AAAAAA

   
Results: 1-21 |
Results: 21

Authors: BOUIX M GOUZI J CHARLEUX B VAIRON JP GUINOT P
Citation: M. Bouix et al., SYNTHESIS OF AMPHIPHILIC POLYELECTROLYTE BLOCK-COPOLYMERS USING LIVING RADICAL POLYMERIZATION - APPLICATION AS STABILIZERS IN EMULSION POLYMERIZATION, Macromolecular rapid communications, 19(4), 1998, pp. 209-213

Authors: GUINOT P TEMSAMANI J
Citation: P. Guinot et J. Temsamani, ANTISENSE OLIGONUCLEOTIDES - A NOVEL THER APEUTIC APPROACH, Pathologie et biologie, 46(5), 1998, pp. 347-354

Authors: GUINOT P
Citation: P. Guinot, ANTISENSE OLIGONUCLEOTIDES AS THERAPY FOR VIRAL-INFECTIONS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 32-32

Authors: TEMSAMANI J GUINOT P
Citation: J. Temsamani et P. Guinot, ANTISENSE OLIGONUCLEOTIDES - A NEW THERAPEUTIC APPROACH, Biotechnology and applied biochemistry, 26, 1997, pp. 65-71

Authors: GUINOT P BRYANT L CHOW TY SAEGUSA T
Citation: P. Guinot et al., RANDOM AND BLOCK 2-ALKYL-2-OXAZOLINES TELECHELIC MACROMONOMERS, Macromolecular chemistry and physics, 197(1), 1996, pp. 1-17

Authors: MARANINCHI D BARBET J BATTAIS J EMILIE D GOEHRS JM GUINOT P MANNONI P MEYER P ROMETLEMONNE JL TROUVIN JH CALVO F GALANAUD P GOUYETTE A JULOU CL MARCEL T MOREL A QUENTINMILLET MJ SCHATZ C WIJDENES J
Citation: D. Maraninchi et al., WHICH STATUS FOR DRUGS OF BIOLOGICAL ORIG IN, Therapie, 51(4), 1996, pp. 431-433

Authors: AUZERIE J COLLE M GUINOT P LAVERGNE V
Citation: J. Auzerie et al., GROWTH-HORMONE RELEASING HORMONE-TREATMEN T IN GROWTH-HORMONE DEFICIENCY - ACTUAL DATA AND FUTURE-PROSPECTS, Archives de pediatrie, 2(4), 1995, pp. 365-372

Authors: HILLIQUIN P GUINOT P CHERMATIZARD V PUECHAL X MENKES CJ
Citation: P. Hilliquin et al., TREATMENT OF RHEUMATOID-ARTHRITIS WITH PLATELET-ACTIVATING-FACTOR ANTAGONIST BN-50730, Journal of rheumatology, 22(9), 1995, pp. 1651-1654

Authors: BROCHET B GUINOT P ORGOGOZO JM CONFAVREUX C RUMBACH L LAVERGNE V BOULLIAT J CAUSSANEL JP CESARO P CHEDRU F COLLARD M DEGOS CF DESTEE A GOAS JY GONSETTE R FEVE JR ROULLET E SETIEY A VIALLET F WARTER JM
Citation: B. Brochet et al., DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY OF GINKGOLIDE-B IN TREATMENT OF ACUTE EXACERBATIONS OF MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 58(3), 1995, pp. 360-362

Authors: HILLIQUIN P NATOUR J AISSA J GUINOT P LAOUSSADI S BENVENISTE J MENKES CJ ARNOUX B
Citation: P. Hilliquin et al., TREATMENT OF CARRAGEENAN-INDUCED ARTHRITIS BY THE PLATELET-ACTIVATING-FACTOR ANTAGONIST BN-50730, Annals of the Rheumatic Diseases, 54(2), 1995, pp. 140-143

Authors: PIGNOL B MAISONNET T GUINOT P MENCIAHUERTA JM BRAQUET P
Citation: B. Pignol et al., EFFECT OF PLATELET-ACTIVATING-FACTOR ON IN-VITRO AND IN-VIVO INTERLEUKIN-6 PRODUCTION, Mediators of inflammation, 3(4), 1994, pp. 281-285

Authors: GUINOT P BRAQUET P
Citation: P. Guinot et P. Braquet, EFFECTS OF THE PAF ANTAGONISTS, GINKGOLIDES (BN-52063, BN-52021), IN VARIOUS CLINICAL INDICATIONS, Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 141-146

Authors: GUINOT P
Citation: P. Guinot, INFLAMMATORY MEMBRANE-DERIVED LIPIDS AND THEIR ANTAGONISTS - INTRODUCTION, Clinical reviews in allergy, 12(4), 1994, pp. 305-307

Authors: GUINOT P
Citation: P. Guinot, CLINICAL-EXPERIENCE WITH PLATELET-ACTIVATING-FACTOR ANTAGONISTS - PAST, PRESENT, AND NEAR FUTURE, Clinical reviews in allergy, 12(4), 1994, pp. 397-417

Authors: DUCHIER J AURICHE C GUINOT P
Citation: J. Duchier et al., EFFECT OF BN-50730, A SPECIFIC PAF ANTAGONIST, ON PAF-INDUCED PLATELET-AGGREGATION AND SKIN-RESPONSES IN HEALTHY-HUMAN VOLUNTEERS, Drug investigation, 8(2), 1994, pp. 95-103

Authors: DHAINAUT JFA TENAILLON A LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP DEVATHAIRE F GUINOT P
Citation: Jfa. Dhainaut et al., PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER CLINICAL-TRIAL, Critical care medicine, 22(11), 1994, pp. 1720-1728

Authors: LAGENTE V BOICHOT E CARRE C GUINOT P MENCIAHUERTA JM BRAQUET P
Citation: V. Lagente et al., EFFECTS OF THE PLATELET-ACTIVATING-FACTOR ANTAGONISTS BN-52021 AND BN-50730 ON ANTIGEN-INDUCED BRONCHIAL HYPERRESPONSIVENESS AND EOSINOPHILINFILTRATION IN LUNG FROM SENSITIZED GUINEA-PIGS, Clinical and experimental allergy, 23(12), 1993, pp. 1002-1010

Authors: DAHAN R JAILLON P LEHNER JP CAZOR JL CLOARECBLANCHARD L DAHAN R DUCHIER J GUINOT P JAILLON P LEHNER JP LOEB F MACQUINMAVIER C PUECH A ROLAND E ROUVEIX B TEULEESPIE M THULLIEZ C VITOU P
Citation: R. Dahan et al., HOW TO PREDICT THE THERAPEUTIC DOSE RANGE TO BE TESTED IN PHASE-III CLINICAL-TRIALS, Therapie, 48(4), 1993, pp. 297-301

Authors: HILLIQUIN P GUINOT P CHERMATIZARD V ARNOUX B MENKES CJ
Citation: P. Hilliquin et al., TREATMENT OF RHEUMATOID-ARTHRITIS (RA) BY A PAF-ACETHER ANTAGONIST (BN 50730) - RESULTS OF AN OPEN STUDY, Arthritis and rheumatism, 36(9), 1993, pp. 190000216-190000216

Authors: TENAILLON A DHAINAUT JF LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP CHRETIEN JM LAVERGNE V GUINOT P
Citation: A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 97-97

Authors: TENAILLON A DHAINAUT JF LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP CHRETIEN JM LAVERGNE V GUINOT P
Citation: A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 196-196
Risultati: 1-21 |